News
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer shows promising results in reducing total parenteral support for MVID patients, presented at NASPGHAN. Jaguar Health's investigation explores breakthrough benefits for pediatric patients with intestinal failure -
-
-
-
COMMUNIQUÉ DE PRESSE
Voltatron AG Advances Transformation and Accelerates Structural Recovery – Equity Turns Positive Following Balance Sheet Strengthening
Voltatron AG reports positive equity and strong financial performance with a 302% rise in group revenue. Transformation and structural recovery accelerate, supported by GMS acquisition -
-
COMMUNIQUÉ DE PRESSE
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Grid AI, a subsidiary of Entero Therapeutics, is establishing a U.S.-based leadership team to expand its AI-ready digital infrastructure in response to the growing global data center market -
-
